Ajanta Pharma Ltd

Common Name
Ajanta Pharma
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
9,628
Ticker
AJANTPHARM
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Ajanta Pharma Ltd. is a leading pharmaceutical company engaged in the development, manufacture, and marketing of a wide range of branded and generic pharmaceuticals. Established in 1973, the company h...

Ajanta Pharma's GHG Emissions Data Preview

In 2025, Ajanta Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

However, Ajanta Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2025202420232022 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Download Data

Verified Sources Behind Ajanta Pharma’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Ajanta Pharma’s data sources below and access millions more through our Disclosure Search.

a. Ajanta Pharma's Annual Report 2025
a. Ajanta Pharma's Annual Report 2025
b. Ajanta Pharma's Annual Report 2023
b. Ajanta Pharma's Annual Report 2023

Insights into Ajanta Pharma's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Ajanta Pharma amounted to 49,990.47 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Ajanta Pharma increased by 7.74%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Ajanta Pharma's Scope 1 Emissions Over Time

202220232024202502 k4 k6 k8 ktCO2e-5%+46%0%
  • Total Scope 1
  • Year-over-Year Change

What are Ajanta Pharma's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Ajanta Pharma were 6,392 metric tons of CO₂ equivalent (tCO₂e). a

Has Ajanta Pharma reduced its Scope 1 emissions over time?

Since 2022, Ajanta Pharma's Scope 1 emissions have increased by 38.62%, reflecting a rising long-term trend in Scope 1 emissions over time. a b

Compared to the previous year (2024), Ajanta Pharma's Scope 1 emissions remained relatively stable, indicating that Ajanta Pharma's emissions have plateaued with no significant change in its operational footprint. a

What are Ajanta Pharma's Scope 2 emissions?

In 2025, Ajanta Pharma reported Scope 2 greenhouse gas (GHG) emissions of 43,598.47 tCO₂e without specifying the calculation method. a

Has Ajanta Pharma reduced its Scope 2 emissions over time?

Since 2022, Ajanta Pharma's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that Ajanta Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a b

Compared to the previous year (2024), Ajanta Pharma's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Ajanta Pharma 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does Ajanta Pharma use for Scope 2 reporting?

In 2025, Ajanta Pharma reported its Scope 2 emissions using an unspecified methodology. a

Ajanta Pharma's Scope 2 Emissions Over Time

2022202320242025015 k30 k45 k60 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Ajanta Pharma's Value Chain Emissions

In 2025, Ajanta Pharma reported 10,790 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2025 disclosure of Ajanta Pharma includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year. a

Ajanta Pharma's Scope 3 Emissions Over Time

202503 k6 k9 k12 ktCO2e
  • Total Scope 3
  • Year-over-Year Change

What are Ajanta Pharma's Scope 3 emissions?

In 2025, Ajanta Pharma reported total Scope 3 emissions of 10,790 metric tons of CO₂ equivalent (tCO₂e). a

Insights into Ajanta Pharma’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Ajanta Pharma reported Scope 1 greenhouse gas (GHG) emissions of 6,392 tCO₂e and total revenues of USD 537 millions. This translates into an emissions intensity of 11.9 tCO₂e per millions USD. a

Ajanta Pharma's Scope 1 Emissions Intensity Compared to Peers

1001,00020,000200,0002,000,000Scope 1 Emissions (tCO2e)502001,0002,00010,000Revenues (Millions of USD)OJIOLCPYear: 2025Scope 1: 45,920 tCO2eRevenue: $M 242Scope 1 Intensity: 189.70 tCO2e/$MDivi's LaboratoriesYear: 2025Scope 1: 339,941 tCO2eRevenue: $M 1,091Scope 1 Intensity: 311.47 tCO2e/$MAurobindo PharmaYear: 2025Scope 1: 750,616 tCO2eRevenue: $M 3,672Scope 1 Intensity: 204.39 tCO2e/$MMankind PharmaYear: 2025Scope 1: 6,538 tCO2eRevenue: $M 1,429Scope 1 Intensity: 4.58 tCO2e/$MZydus LifesciencesYear: 2023Scope 1: 44,792 tCO2eRevenue: $M 2,056Scope 1 Intensity: 21.79 tCO2e/$MAarti PharmalabsYear: 2024Scope 1: 88,101 tCO2eRevenue: $M 218Scope 1 Intensity: 404.68 tCO2e/$MAlembic PharmaceuticalsYear: 2025Scope 1: 80,278 tCO2eRevenue: $M 765Scope 1 Intensity: 104.88 tCO2e/$MAbbott IndiaYear: 2025Scope 1: 232 tCO2eRevenue: $M 750Scope 1 Intensity: 0.31 tCO2e/$MCiplaYear: 2025Scope 1: 38,283 tCO2eRevenue: $M 3,177Scope 1 Intensity: 12.05 tCO2e/$MJB PharmaYear: 2025Scope 1: 5,652 tCO2eRevenue: $M 452Scope 1 Intensity: 12.50 tCO2e/$MNatco PharmaYear: 2025Scope 1: 28,495 tCO2eRevenue: $M 518Scope 1 Intensity: 54.96 tCO2e/$MGlenmark PharmaceuticalsYear: 2025Scope 1: 34,547 tCO2eRevenue: $M 1,539Scope 1 Intensity: 22.45 tCO2e/$MTorrent PharmaceuticalsYear: 2025Scope 1: 8,937 tCO2eRevenue: $M 1,325Scope 1 Intensity: 6.75 tCO2e/$MStrides Pharma ScienceYear: 2023Scope 1: 6,168 tCO2eRevenue: $M 439Scope 1 Intensity: 14.04 tCO2e/$MCohance LifesciencesYear: 2025Scope 1: 31,818 tCO2eRevenue: $M 140Scope 1 Intensity: 227.00 tCO2e/$MOOOrchid PharmaYear: 2025Scope 1: 74,800 tCO2eRevenue: $M 108Scope 1 Intensity: 693.22 tCO2e/$MAlkem LaboratoriesYear: 2025Scope 1: 33,018 tCO2eRevenue: $M 1,499Scope 1 Intensity: 22.03 tCO2e/$MGland PharmaYear: 2025Scope 1: 13,920 tCO2eRevenue: $M 654Scope 1 Intensity: 21.30 tCO2e/$MLupinYear: 2025Scope 1: 82,174 tCO2eRevenue: $M 2,597Scope 1 Intensity: 31.64 tCO2e/$MSun Pharmaceutical IndustriesYear: 2025Scope 1: 156,242 tCO2eRevenue: $M 6,091Scope 1 Intensity: 25.65 tCO2e/$MPiramal PharmaYear: 2025Scope 1: 61,351 tCO2eRevenue: $M 1,061Scope 1 Intensity: 57.85 tCO2e/$MIPCA LaboratoriesYear: 2025Scope 1: 169,992 tCO2eRevenue: $M 1,036Scope 1 Intensity: 164.03 tCO2e/$MJJJubilant PharmovaYear: 2025Scope 1: 10,084 tCO2eRevenue: $M 842Scope 1 Intensity: 11.98 tCO2e/$MGranules IndiaYear: 2024Scope 1: 58,254 tCO2eRevenue: $M 538Scope 1 Intensity: 108.19 tCO2e/$MAjanta PharmaYear: 2025Scope 1: 6,392 tCO2eRevenue: $M 537Scope 1 Intensity: 11.90 tCO2e/$M

How does Ajanta Pharma's GHG emissions intensity compare to its peers?

In 2025, Ajanta Pharma reported a Scope 1 emissions intensity of 11.9 tCO₂e per millions USD. Compared to the peer group median of 28.64 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Ajanta Pharma rank on GHG emissions intensity within its industry?

In 2025, Ajanta Pharma ranked 4 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Ajanta Pharma among the top performers, with one of the lowest emissions intensities relative to peers. a

Insights into Ajanta Pharma's Total Carbon Footprint

In 2025, Ajanta Pharma reported a total carbon footprint of 60,780.47 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 31% increase compared to 2024, suggesting a rise in emissions across its operations or value chain. a

The largest contributor to Ajanta Pharma's total carbon footprint was Scope 2 emissions, accounting for 71.73% of the company's total carbon footprint, followed by Scope 3 emissions at 17.75%. a

Want Full Access to Ajanta Pharma's GHG Emissions Dataset?
Sign Up